Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-(3'-tert-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole Hydrochloride
2. Arotinolol
3. Arotinolol, (+-)-isomer
4. S 596
5. S-596
1. 68377-91-3
2. Arotinolol Hcl
3. Arotinolol Hydrochloride [jan]
4. Arotinolol (hydrochloride)
5. 9doi1ht306
6. 2-thiophenecarboxamide, 5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-, Monohydrochloride, (+-)-
7. 68377-91-3 (hcl)
8. 5-[2-[[3-(tert-butylamino)-2-hydroxypropyl]thio]thiazol-4-yl]thiophene-2-carboxamide Hydrochloride
9. 5-[2-[3-(tert-butylamino)-2-hydroxypropyl]sulfanyl-1,3-thiazol-4-yl]thiophene-2-carboxamide;hydrochloride
10. S 596
11. Unii-9doi1ht306
12. Almarl (tn)
13. Arotinololhydrochloride
14. Ncgc00181107-01
15. S-596
16. (+-)-2-(3'-tert-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole Hcl
17. Dsstox_cid_26849
18. Dsstox_rid_81958
19. Dsstox_gsid_46849
20. Schembl348620
21. Arotinolol Hydrochloride,(s)-
22. Chembl3185966
23. Dtxsid1046849
24. Arotinolol Hydrochloride (jp17)
25. Chebi:31239
26. Bcp06721
27. Bcp28628
28. Tox21_112721
29. Arotinolol Hydrochloride [mi]
30. Mfcd00941421
31. Arotinolol Hydrochloride [mart.]
32. Arotinolol Hydrochloride [who-dd]
33. As-76884
34. Arotinolol Hcl;(s)-arotinolol Hydrochloride
35. Cas-68377-91-3
36. Db-055145
37. Ft-0602864
38. D01830
39. F20661
40. 377a913
41. Q27272409
42. (+/-)-2-(3'-tert-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole Hcl
43. 2-thiophenecarboxamide, 5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-, Monohydrochloride, (+/-)-
44. 5-(2-(3-(tert-butylamino)-2-hydroxypropylthio)thiazol-4-yl)thiophene-2-carboxamide Hydrochloride
Molecular Weight | 408.0 g/mol |
---|---|
Molecular Formula | C15H22ClN3O2S3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 8 |
Exact Mass | 407.0562682 g/mol |
Monoisotopic Mass | 407.0562682 g/mol |
Topological Polar Surface Area | 170 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 406 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adrenergic beta-Antagonists
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)
Adrenergic alpha-Antagonists
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
ABOUT THIS PAGE
75
PharmaCompass offers a list of Arotinolol Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Arotinolol Hydrochloride manufacturer or Arotinolol Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Arotinolol Hydrochloride manufacturer or Arotinolol Hydrochloride supplier.
PharmaCompass also assists you with knowing the Arotinolol Hydrochloride API Price utilized in the formulation of products. Arotinolol Hydrochloride API Price is not always fixed or binding as the Arotinolol Hydrochloride Price is obtained through a variety of data sources. The Arotinolol Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Almarl (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Almarl (TN), including repackagers and relabelers. The FDA regulates Almarl (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Almarl (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Almarl (TN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Almarl (TN) supplier is an individual or a company that provides Almarl (TN) active pharmaceutical ingredient (API) or Almarl (TN) finished formulations upon request. The Almarl (TN) suppliers may include Almarl (TN) API manufacturers, exporters, distributors and traders.
click here to find a list of Almarl (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Almarl (TN) Drug Master File in Japan (Almarl (TN) JDMF) empowers Almarl (TN) API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Almarl (TN) JDMF during the approval evaluation for pharmaceutical products. At the time of Almarl (TN) JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Almarl (TN) suppliers with JDMF on PharmaCompass.
Almarl (TN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Almarl (TN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Almarl (TN) GMP manufacturer or Almarl (TN) GMP API supplier for your needs.
A Almarl (TN) CoA (Certificate of Analysis) is a formal document that attests to Almarl (TN)'s compliance with Almarl (TN) specifications and serves as a tool for batch-level quality control.
Almarl (TN) CoA mostly includes findings from lab analyses of a specific batch. For each Almarl (TN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Almarl (TN) may be tested according to a variety of international standards, such as European Pharmacopoeia (Almarl (TN) EP), Almarl (TN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Almarl (TN) USP).